The partial amino acid sequence of a wild-type protein is
… Arg-Met-Tyr-Thr-Leu-Cys-Ser …
The same portion of the protein from a mutant has the sequence
… Arg-Met-Leu-Tyr-Ala-Leu-Phe …
Give the sequence of the wild-type DNA template strand. Use A/G if the nucleotide could be either purine, T/C if it could be either pyrimidine, N if any nucleotide could occur at a site, or the alternative nucleotides if a purine and a pyrimidine are possible.

Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of-function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain-of-function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently being used in clinical trials involves the 'addition' to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?

A significant number of mutations in the HBB gene that cause human β-thalassemia occur within introns or in upstream noncoding sequences. Explain why mutations in these regions often lead to severe disease, although they may not directly alter the coding regions of the gene.

Using the adenine–thymine base pair in this DNA sequence

...GCTC...

...CGAG...

Give the sequence after a transversion mutation.

Using the adenine–thymine base pair in this DNA sequence

...GCTC...

...CGAG...

Give the sequence after a transition mutation.

The partial amino acid sequence of a wild-type protein is

… Arg-Met-Tyr-Thr-Leu-Cys-Ser …

The same portion of the protein from a mutant has the sequence

… Arg-Met-Leu-Tyr-Ala-Leu-Phe …

Identify the type of mutation.

Speculate on how improved living conditions and medical care in the developed nations might affect human mutation rates, both neutral and deleterious.

The two DNA and polypeptide sequences shown are for alleles at a hypothetical locus that produce different polypeptides, both five amino acids long. In each case, the lower DNA strand is the template strand:

Based on DNA and polypeptide sequences alone, is there any way to determine which allele is dominant and which is recessive? Why or why not?

Many human genes are known to have homologs in the mouse genome. One approach to investigating human hereditary disease is to produce mutations of the mouse homologs of human genes by methods that can precisely target specific nucleotides for mutation.

Despite the homologies that exist between human and mouse genes, some attempts to study human hereditary disease processes by inducing mutations in mouse genes indicate there is little to be learned about human disease in this way. In general terms, describe how and why the study of mouse gene mutations might fail to produce useful information about human disease processes.